Hence, we conclude that hepatic RIG-I deficiency suppresses NASH and NASH-induced HCC, and the tumor-promotive role of RIG-I in NASH-induced HCC is opposite to the tumor-suppressive role of RIG-I in DEN-induced hepatocarcinogenesis. Here, RIGI is linked to hepatocellular carcinoma.